Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden

被引:54
作者
Roach, Jared C.
Deutsch, Kerry
Li, Sarah
Siegel, Andrew F.
Bekris, Lynn M.
Einhaus, Derek C.
Sheridan, Colleen M.
Glusman, Gustavo
Hood, Leroy
Lernmark, Ake
Janer, Marta
机构
[1] Univ Washington, Inst Syst Biol, Seattle, WA 98103 USA
[2] Univ Washington, Dept Stat, Seattle, WA 98103 USA
[3] Univ Washington, Dept Management Sci & Finance & Business Econ, Seattle, WA 98103 USA
[4] Univ Washington, Dept Med, Seattle, WA 98103 USA
关键词
D O I
10.1086/507876
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We mapped the genetic influences for type 1 diabetes (T1D), using 2,360 single-nucleotide polymorphism ( SNP) markers in the 4.4-Mb human major histocompatibility complex (MHC) locus and the adjacent 493 kb centromeric to the MHC, initially in a survey of 363 Swedish T1D cases and controls. We confirmed prior studies showing association with T1D in the MHC, most significantly near HLA-DR/DQ. In the region centromeric to the MHC, we identified a peak of association within the inositol 1,4,5-triphosphate receptor 3 gene (ITPR3; formerly IP3R3). The most significant single SNP in this region was at the center of the ITPR3 peak of association (P = 1.7 x 10(-4) the survey study). For validation, we typed an additional 761 Swedish individuals. The P value for association computed from all 1,124 individuals was (recessive odds ratio 2.5; 95% confidence interval [CI] 1.7 - 3.9). The estimated population-attributable risk 1.30 x 10(-6) of 21.6% (95% CI 10.0% - 31.0%) suggests that variation within ITPR3 reflects an important contribution to T1D in Sweden. Two-locus regression analysis supports an influence of ITPR3 variation on T1D that is distinct from that of any MHC class II gene.
引用
收藏
页码:614 / 627
页数:14
相关论文
共 45 条
[1]   Adaptive hitchhiking effects on genome variability [J].
Andolfatto, P .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (06) :635-641
[2]   Type 1 diabetes: new perspectives on disease pathogenesis and treatment [J].
Atkinson, MA ;
Eisenbarth, GS .
LANCET, 2001, 358 (9277) :221-229
[3]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[4]   The inositol 1,4,5-trisphosphate receptors [J].
Bezprozvanny, I .
CELL CALCIUM, 2005, 38 (3-4) :261-272
[5]   Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium [J].
Carlson, CS ;
Eberle, MA ;
Rieder, MJ ;
Yi, Q ;
Kruglyak, L ;
Nickerson, DA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (01) :106-120
[6]  
CHRISTIANSEN FB, 1977, AM J HUM GENET, V29, P195
[7]   The HLA component of type I diabetes [J].
Clerget-Darpoux, F .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (04) :1468-1468
[8]   Type 1 diabetes - Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families [J].
Concannon, P ;
Erlich, HA ;
Julier, C ;
Morahan, G ;
Nerup, J ;
Pociot, F ;
Todd, JA ;
Rich, SS .
DIABETES, 2005, 54 (10) :2995-3001
[9]   High-resolution patterns of meiotic recombination across the human major histocompatibility complex [J].
Cullen, M ;
Perfetto, SP ;
Klitz, W ;
Nelson, G ;
Carrington, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) :759-776
[10]   A GENOME-WIDE SEARCH FOR HUMAN TYPE-1 DIABETES SUSCEPTIBILITY GENES [J].
DAVIES, JL ;
KAWAGUCHI, Y ;
BENNETT, ST ;
COPEMAN, JB ;
CORDELL, HJ ;
PRITCHARD, LE ;
REED, PW ;
GOUGH, SCL ;
JENKINS, SC ;
PALMER, SM ;
BALFOUR, KM ;
ROWE, BR ;
FARRALL, M ;
BARNETT, AH ;
BAIN, SC ;
TODD, JA .
NATURE, 1994, 371 (6493) :130-136